Efficiency of Using Osseodensification Protocol

May 18, 2024 updated by: Mohamed Magdy Mostafa Shehata

Efficiency of Using Osseodensification Protocol for Alveolar Ridge Expansion in Edentulous Alveolar Ridges

the goal of this clinical trial is to learn if the new osseo-densification technique works to provide enough bone width and quality prior to implant placement in the upper jaw the main question it aims to answer is: Is the use of osseo-densification protocol better than the standard alveolar ridge widening techniques; regarding efficiency and comfort in obtaining sufficient alveolar ridge width in horizontally atrophic alveolar ridges?

Study Overview

Detailed Description

a new osseo-densification protocol using specially designed Densah burs was compared to conventional hand Osteotome technique to test its efficiency in providing sufficient bone quantity and quality in cases of horizontally deficient maxillary edentulous alveolar ridge sites that require expansion prior to dental implant placement

Study Type

Interventional

Enrollment (Actual)

18

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 11799
        • Mohamed Magdy Mostafa shehata

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age ≥18 years old.
  • In cases of an initial ridge width ≤ 5mm that contains ≤ 2mm of trabecular bone core.
  • Alveolar ridges with narrow crest and wider base.

Exclusion Criteria:

  • Uncontrolled diabetic patients
  • Heavy Smokers
  • Patients suffering from osteoporosis
  • Patients receiving chemo or radio therapy
  • Patients suffering from bleeding disorders
  • Patients suffering from intraosseous lesions at the proposed site of implant
  • Patients with insufficient alveolar bone hight less than 10 mm.
  • Resorbed ridge with a narrow base.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention group osseodensification
the group in which alveloalr ridge widening is done using densah burs, it is the study group
alveolar ridge expansion using densah burs in horizontally deficient maxillary alveolar ridges prior to dental implants insertion
Active Comparator: conventional osteotome group
the group in which alveolar ridge expansion is done using hand driven osteotomes . it is the conventional froup
Alveolar ridge expansion using hand driven osteotomes in horizontally deficient maxillary alveolar ridges prior to dental Implant insertion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
efficiency of ridge widening technique
Time Frame: intraoperative and within 3 days post operative
the amount of ridge width gain is measured both clinically via a caliber and radiographically on CBCT
intraoperative and within 3 days post operative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
primary stability of implant
Time Frame: intra-operative after dental implant placement
the primary stability of the inserted dental implant is measured via osstell device
intra-operative after dental implant placement
length of surgical procedure
Time Frame: During surgery
the time required for completion of the surgical procedure is measured in minutes using stop watch
During surgery
Value of pain
Time Frame: Immediate post operative
the degree of pain or discomfort examined by the patient during the ridge widening procedure is recorded using a visual scale where 0 represents no pain while 1 minimum pain and 10 is maximum pain
Immediate post operative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Mohamed M Shehata, Cairo University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 15, 2022

Primary Completion (Actual)

January 20, 2024

Study Completion (Actual)

February 15, 2024

Study Registration Dates

First Submitted

May 9, 2024

First Submitted That Met QC Criteria

May 18, 2024

First Posted (Actual)

May 23, 2024

Study Record Updates

Last Update Posted (Actual)

May 23, 2024

Last Update Submitted That Met QC Criteria

May 18, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 28908210103756

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all IPD that underlie results in a publication

IPD Sharing Time Frame

within 6 months from publication

IPD Sharing Access Criteria

IDP will be shared with researchers and clinical investigators who require them for further systematic review or retrograde studies via contacting the principal investigator through email

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Resorption

Subscribe